PAPP, K. A.; MEROLA, J. F.; GOTTLIEB, A. B.; GRIFFITHS, C. E.; HARRIS, K. K.; CROSS, N.; PETERSON, L.; CIOFFI, C.; BLAUVELT, A. Bimekizumab provides rapid and sustained improvements in quality of life that correlate with clinical outcomes in patients with moderate to severe plaque psoriasis: 60 week results from a randomized , double blinded , Phase 2b extension study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 3, p. S35, 2019. DOI: 10.25251/skin.3.supp.35. Disponível em: https://jofskin.org/index.php/skin/article/view/762. Acesso em: 22 jul. 2024.